Form 4 for ACH ACCENDRA HEALTH INC/VA/
Accepted 2021-11-04 00:00:00 ET · period of report 2021-11-03 · accession 0001062993-21-010279 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-11-04 | 2021-11-03 | ACH | Lowry Michael Wayne | SVP, Corp. Ctrl | S - Sale | $42.10 | -32.6K | 98.3K | -25% | -$1.37M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-03 | S | D | 3,474 | $41.33 | 99,194 | D | — | — | (F1) The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective May 7, 2021. (F2) Weighted average of the sale price range of $41.26 through $41.55 |
| 2 | Common | Common Stock | 2021-11-03 | S | D | 1,348 | $45.32 | 70,037 | D | — | — | (F1) The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective May 7, 2021. (F16) Weighted average of the sale price range of $45.07 through $45.53 |
| 3 | Common | Common Stock | 2021-11-03 | S | D | 501 | $42.75 | 97,810 | D | — | — | (F1) The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective May 7, 2021. (F4) Weighted average of the sale price range of $42.53 through $43.20 |
| 4 | Common | Common Stock | 2021-11-03 | S | D | 184 | $44.24 | 97,626 | D | — | — | (F1) The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective May 7, 2021. (F5) Weighted average of the sale price range of $43.97 through $44.78 |
| 5 | Common | Common Stock | 2021-11-03 | S | D | 138 | $45.30 | 97,488 | D | — | — | (F1) The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective May 7, 2021. (F6) Weighted average of the sale price range of $45.21 through $45.32 |
| 6 | Common | Common Stock | 2021-11-03 | S | D | 4,261 | $41.43 | 93,227 | D | — | — | (F1) The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective May 7, 2021. (F7) Weighted average of the sale price range of $41.12 through $42.11 |
| 7 | Common | Common Stock | 2021-11-03 | S | D | 1,500 | $42.62 | 91,727 | D | — | — | (F1) The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective May 7, 2021. (F8) Weighted average of the sale price range of $42.20 through $42.98 |
| 8 | Common | Common Stock | 2021-11-03 | S | D | 400 | $43.86 | 91,327 | D | — | — | (F1) The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective May 7, 2021. (F9) Weighted average of the sale price range of $43.39 through $44.11 |
| 9 | Common | Common Stock | 2021-11-03 | S | D | 517 | $45.19 | 90,810 | D | — | — | (F1) The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective May 7, 2021. (F10) Weighted average of the sale price range of $44.59 through $45.43 |
| 10 | Common | Common Stock | 2021-11-03 | S | D | 5,169 | $41.33 | 85,641 | D | — | — | (F1) The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective May 7, 2021. (F11) Weighted average of the sale price range of $41.26 through $41.55 |
| 11 | Common | Common Stock | 2021-11-03 | S | D | 6,452 | $41.44 | 79,189 | D | — | — | (F1) The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective May 7, 2021. (F12) Weighted average of the sale price range of $40.68 through $41.55 |
| 12 | Common | Common Stock | 2021-11-03 | S | D | 4,104 | $42.35 | 75,085 | D | — | — | (F1) The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective May 7, 2021. (F13) Weighted average of the sale price range of $41.74 through $42.71 |
| 13 | Common | Common Stock | 2021-11-03 | S | D | 2,500 | $42.95 | 72,585 | D | — | — | (F1) The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective May 7, 2021. (F14) Weighted average of the sale price range of $42.74 through $43.68 |
| 14 | Common | Common Stock | 2021-11-03 | S | D | 1,200 | $44.22 | 71,385 | D | — | — | (F1) The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective May 7, 2021. (F15) Weighted average of the sale price range of $43.74 through $44.73 |
| 15 | Common | Common Stock | 2021-11-03 | S | D | 883 | $41.64 | 98,311 | D | — | — | (F1) The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective May 7, 2021. (F3) Weighted average of the sale price range of $41.41 through $42.34 |